AAAAAA

   
Results: 1-6 |
Results: 6

Authors: LIARD F JARAMILLO J PARIS WL YOAKIM C
Citation: F. Liard et al., PHARMACOKINETIC ASPECTS OF PALINAVIR, AN HIV PROTEASE INHIBITOR, IN SPRAGUE-DAWLEY RATS, Journal of pharmaceutical sciences, 87(6), 1998, pp. 782-785

Authors: LEFLOCH JP DUPRATLOMON I ESCHWEGE EL LIARD F GRIMALDI A
Citation: Jp. Lefloch et al., MANAGEMENT OF 5548 PATIENTS WITH TYPE-II DIABETES FOLLOWED BY GENERAL-PRACTITIONERS IN FRANCE, 1997, Diabetes, 47, 1998, pp. 1486-1486

Authors: BOLGER GT ALLEN T GARNEAU M LAPEYRE N LIARD F JARAMILLO J
Citation: Gt. Bolger et al., CUTANEOUSLY APPLIED ACYCLOVIR ACTS SYSTEMICALLY IN THE TREATMENT OF HERPETIC INFECTION IN THE HAIRLESS MOUSE, Antiviral research, 35(3), 1997, pp. 157-165

Authors: BEAULIEU PL WERNIC D ABRAHAM A ANDERSON PC BOGRI T BOUSQUET Y CROTEAU G GUSE I LAMARRE D LIARD F PARIS W THIBEAULT D PAV S TONG L
Citation: Pl. Beaulieu et al., POTENT HIV PROTEASE INHIBITORS CONTAINING A NOVEL (HYDROXYETHYL)AMIDEISOSTERE, Journal of medicinal chemistry, 40(14), 1997, pp. 2164-2176

Authors: LIARD F GHIRO E PARIS W YOAKIM C
Citation: F. Liard et al., DETERMINATION OF THE HIV PROTEASE INHIBITOR BILA-2185-BS IN RAT PLASMA BY LIQUID-LIQUID-EXTRACTION AND HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY PHOTODIODE-ARRAY DETECTOR, Journal of pharmaceutical and biomedical analysis, 14(1-2), 1995, pp. 151-154

Authors: GENTHON R RANGOONWALA B ANDRIEUXLACLAVELINE A ARNAUD J BALLADE M BILLOU J BOSREDON A BOUTGES B DUBON T GOIGOUX B LALANNE G LAURENTJOYE F LION A LORANS P MAURAT X MOULINET P RICARD L ROCHE A SDRIGOTTI D SDRIGOTTI J BUGNON P DELOGE J GENIN M JACSON P LAMIZET P MOURAUX J STRAUSS P TAQUE R VINCENT J BOULEN Y BOYAVAL B DANDOY P DELESCLUSE D DENIS X DERMAUT G DEROIDE F GHIENNE JP HERMEL R JAILLARD T MANIGLIER G MEURISSE F RICHARD G TIBERGHIEN P VANDENDRIESSCHE P VANNIER P AGNIEL P ARMAND C BOICHON P BOULE G CHAPPUY D CORMARY M DUMORTIER J DURAND JY GUEZ C HOBEIKA A HUCHON J LEAMMER G LAFUMA G LEVRAT P MEDIONI J MORIN MM CASABIANCACHICKLY M CECILE A DEREGIS H DESENCLOS J LEMIERE JM OVANON G RAINITSIMBA M RECORBET G ROBIN P ZINI G BAUMANN M BOCCARA J COUDRY A DIETRICH J FROIDEVAUX J KENTZINGER J MEYER P NEFF G PICA D ROBERT J VOGT P COZIC J DAHAN G DARTIGE JJ ELKOURI J EOCHE R FORTIS A GOURE P HAMEL NH LECOY C MANSEAU J PERIMONY C PIQUET P PONTONNIER J SUPIOT JL BENDAVID N BERGER P COLETTI M HADJADJ P HOLSTEIN M ROUGERON C SERERO A ANDRES F ATTUIL R BEFORT A BIDET P BIRRY G GUY I HARTMANN G SCHLEWITZ T COCHET D COGNEAU J CONAN M FITOUSSI W GIACOMINO A LEBLEU P LECALIER A LIARD F PALEOLOGUE F PERSONNIC S ROFFAY J SALMON T SERRE C THIMEL S BAUER B LENDRESSE P CARCONE N DELMAS F DENAES R SADORGE C DEROBERT E LEMARIE JC THEOBALD KH BOURDEREAU G IROUDAYASSAMY R SAMSONTHOMAS L FRAMPTON H CARRE A FILLASTRE JP GALLET M IMBS JL PLOUIN PF
Citation: R. Genthon et al., STUDY OF THE EFFICACY AND SAFETY OF THE COMBINATION RAMIPRIL 2.5-MG PLUS HYDROCHLOROTHIAZIDE 12.5-MG IN PATIENTS WITH MILD-TO-MODERATE HYPERTENSION, International journal of clinical pharmacology research, 14(1), 1994, pp. 1-9
Risultati: 1-6 |